PLA2G4F/PPARGC1A and ACOT6/HMGCLL1 increased stepwise with the gradual deterioration of liver function, aiding in reflecting the differential changes in biological activities at different HCC stages (see Fig. 2A,B). This evidence concerns the gene PPARGC1A and hepatocellular carcinoma.